Medac Gesellschaft für klinische Spezialpräparate mbH (manufacturer responsible for batch release, labeling and secondary packaging)

The drug is used for adjuvant therapy of stage III colorectal cancer after tumor removal, as well as for the treatment of metastatic colorectal cancer (usually in combination with other drugs).

Dosage form: concentrate for infusion solution

ATC: L01XA03